Early research (Phase 1)Active Not RecruitingNCT05743595
What this trial is testing
Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma
Who this might be right for
Unmethylated Glioblastoma
Washington University School of Medicine 27